Cipher Pharmaceuticals Net Income

The latest net income for CPHRF is $29M as of June 2026. That compares with $12M in the prior-year period — up 138.8% year over year. That is below the Healthcare sector average of $16B. Investors often review this figure alongside Cipher Pharmaceuticals's historical trend and sector peers before judging valuation or financial health.

Over the past year, CPHRF's net income moved from $12M to $29M — a 138.8% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Cipher Pharmaceuticals's operating scale or balance-sheet position.

Against Healthcare companies, CPHRF currently prints $29M for net income, while the sector average sits near $16B. That is roughly 99.8% below the sector mean. Large gaps often invite a closer look at Cipher Pharmaceuticals's growth, margins, and balance sheet.

A net income figure of $29M for CPHRF is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $16B. Explore the charts below for those layers of context.

After noting CPHRF's net income ($29M), review year-over-year change from $12M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.